Description

Argipressin,-(1-Mercaptocyclohexaneacetic Acid)(1)-Tyr(2)-Val(4)- CAS NO 81094-15-7 is a synthetic analogue of the neurohypophysial hormone arginine vasopressin, modified to enhance receptor selectivity and metabolic stability. This compound is critical for advanced research in endocrinology and for the development of novel therapeutic agents targeting vasopressin receptors. It is primarily utilized by pharmaceutical R&D departments, academic research institutions, and biotechnology companies focused on cardiovascular, renal, and central nervous system disorders.

Application

• Pharmacological Research: Used as a reference standard and active agent in studies investigating vasopressin V1a and V2 receptor function, signal transduction, and physiological effects.
• Drug Discovery & Development: Serves as a key intermediate or lead compound in the synthesis of new peptide-based therapeutics for conditions like diabetes insipidus, septic shock, and hypertension.
• Biochemical Assays: Employed in competitive binding assays, enzyme-linked immunosorbent assays (ELISAs), and other in vitro tests to study hormone-receptor interactions and screen for antagonists or agonists.
• Academic Studies: Facilitates fundamental research in physiology and neuroendocrinology to understand water balance, blood pressure regulation, and social behavior mechanisms.
• Peptide Chemistry: Acts as a model compound for studying structure-activity relationships (SAR) and for developing novel peptide synthesis and modification techniques.

Basic Information

Product Name	Argipressin,-(1-Mercaptocyclohexaneacetic Acid)(1)-Tyr(2)-Val(4)- CAS NO 81094-15-7
CAS No.	81094-15-7
Molecular Formula	C46H65N13O12S2
Molecular Weight	1040.2 g/mol
Synonyms	[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-(O-methyl-L-tyrosine), 4-L-valine]arginine vasopressin; d(CH2)5[Tyr(Me)2,Val4]AVP; Desmopressin analogue; Vasopressin V1a receptor antagonist; Manning compound; [1-β-Mercaptocyclopentaneacetic acid, 2-O-methyltyrosine, 4-valine]Arg-vasopressin; Cyclohexaneacetic acid vasopressin derivative
EINECS	Contact for details

Quality Control

Our Argipressin,-(1-Mercaptocyclohexaneacetic Acid)(1)-Tyr(2)-Val(4)- CAS NO 81094-15-7 is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, MS for identity confirmation, and tests for related substances and residual solvents, to ensure compliance with high-purity research-grade standards. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. Under these conditions, the product is stable for extended periods. Due to its hygroscopic and easily oxidized nature, it is recommended to store the product under an inert atmosphere (e.g., argon or nitrogen) after opening and to allow the vial to equilibrate to room temperature before opening to minimize moisture condensation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Single Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 2.0%
Water Content (KF)	≤ 5.0%
Peptide Content (Amino Acid Analysis)	≥ 80.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.